In our clinical studies, we cooperate with Czech CRO which has age-old experience in this area and an excellent group of investigators, medical staff, bioanalytics, biostatistics and study coordinators.
All clinical trials run according to the Principles of Good Clinical Practice (GCP).
As part of a clinical study, the company compared its developed product with the best marketed product for the treatment of migraine. As expected, the company's product achieved better results, bioavailability increased by almost 50%, which, in particular for pharmaceutical products, can significantly contribute to reducing the dose of the drug while maintaining the therapeutic effect and consequently reducing the risk of adverse effects.
Based on the in vivo study, the possibility of using InStrip™ technology in the field of proteins, peptides or other biologically active substances that are thermolabile was further confirmed.